Register Login

Abiopharma

  • Home
  • About
  • Newsroom
  • Company List
  • Events
  • Automated Tools
  • Contact

News list

SL GREEN REALTY CORP (SLG)

  • Business News
  • June 01, 2026, 11:30 UTC
  • 2
  • 1 comments

SL Green Announces the Sale of 10 East 53rd Street

Market reaction Comment Full text

BIOHAVEN LTD. (BHVN)

  • Business News
  • June 01, 2026, 11:30 UTC
  • 3
  • 1 comments

Biohaven Reports First-in-Human Dosing of Oral PKM2 Modulator, BHV-8100, Targeting Metabolic Restoration and Immunomodulation

Market reaction Comment Full text

XCHG LTD (XCH)

  • Business News
  • June 01, 2026, 11:30 UTC
  • 2
  • 1 comments

XCharge Appoints Albina Iljasov as Co-Chief Executive Officer

Market reaction Comment Full text

IMAX CORP (IMAX)

  • Business News
  • June 01, 2026, 11:30 UTC
  • 3
  • 1 comments

Asian Cinemas and IMAX Launch Partnership With Three New IMAX With Laser Locations In India

Market reaction Comment Full text

BOSTON SCIENTIFIC CORP (BSX)

  • Business News
  • June 01, 2026, 11:30 UTC
  • 1
  • 1 comments

Belo Sun Announces Corporate Update

Market reaction Comment Full text

HCI GROUP, INC. (HCI)

  • Business News
  • June 01, 2026, 11:30 UTC
  • 3
  • 1 comments

HCI Group Announces Completion of its 2026-2027 Catastrophe Reinsurance Programs

Market reaction Comment Full text

IOVANCE BIOTHERAPEUTICS, INC. (IOVA)

  • Business News
  • June 01, 2026, 11:30 UTC
  • 1
  • 1 comments

Iovance Biotherapeutics Announces Clearance of Investigational New Drug (IND) Application for IL-12 Tethered TIL Therapy IOV-5001

Market reaction Comment Full text

Biohaven Pharmaceutical Holding Company Ltd. (BHVN)

  • Business News
  • June 01, 2026, 11:30 UTC
  • 1
  • 1 comments

Biohaven Reports First-in-Human Dosing of Oral PKM2 Modulator, BHV-8100, Targeting Metabolic Restoration and Immunomodulation

Market reaction Comment Full text

TG THERAPEUTICS, INC. (TGTX)

  • Business News
  • June 01, 2026, 11:30 UTC
  • 2
  • 1 comments

TG Therapeutics Announces Publication of Post-Hoc Data from the Phase 3 ULTIMATE I & II Trials in Treatment Naive Patients with Relapsing Forms of MS Published in Frontiers in Immunology

Market reaction Comment Full text

COGNITION THERAPEUTICS INC (CGTX)

  • Business News
  • June 01, 2026, 11:30 UTC
  • 2
  • 1 comments

Cognition Therapeutics Participating in Upcoming Investor Conferences

Market reaction Comment Full text
  • Previous
  • 685
  • 686
  • 687
  • 688
  • 689
  • Next

Search

News categories

  • Technical Exchange News(13116)
  • Event(6229)
  • SEC News(328517)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(183564)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin